InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: jimtash post# 27557

Thursday, 02/12/2015 12:00:48 AM

Thursday, February 12, 2015 12:00:48 AM

Post# of 30046
No Jim, it is not true. The technology never had much if any value at all.

It is a funny thing about pan cancer markers. That is the official terminology for a universal cancer marker. Lay people think it is something fantastic. A single test to tell you if you have cancer? What could be better. People would throw there money at it thinking it was a great investment. There are lots of markers that were never pursued and those that have have never gotten anywhere. RECAF was one of them where a "doctor" of sorts scammed millions from investors before finally having the stock revoked. Panacea never went public with their HaaH marker until they went to Canada and it is now a penny stock going nowhere.

There always seems to be a sucker to buy into the hype pushed by a CEO's but it is now getting harder to scam money from investors. Charter can't get anyone to buy into his spit test and WG cant find any financing for his lung test and they never will. Even the most stupid investors at least want patents. Biocurex had a patent. Panacea had a patent. Radient had a patent but they have all expired and two of them had their share registration revoked.

What's wrong with a pan cancer marker? Too many false positives and it does not tell you where the cancer is if you actually have one. I remember a real medical doctor calling RECAF "interesting but a waste of time and money". I remember posters on IHUB saying, "gasp, what's wrong with that doctor." "He probably isn't a real doctor."

I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.